[1] Kaneko T, Kanno C, IchikawaTomikawa N, et al. Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via upregulation of ABCA1 expression[J]. Oncotarget, 2015, 6(32): 3334533357. DOI: 10.18632/oncotarget.5428.
[2] Smith B, Land H. Anticancer activity of the cholesterol exporter ABCA1 gene[J]. Cell Rep, 2012, 2(3): 580590. DOI: 10.1016/j.celrep.2012.08.011.
[3] Chou JL, Huang RL, Shay J, et al. Hypermethylation of the TGFβ target, ABCA1 is associated with poor prognosis in ovarian cancer patients[J]. Clin Epigenetics, 2015, 7(1): 1. DOI: 10.1186/s1314801400362.
[4] Zhao W, Prijic S, Urban BC, et al. Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity[J]. Cancer Res, 2016, 76(7): 20372049. DOI: 10.1158/00085472.CAN151970.
[5] Vargas T, MorenoRubio J, Herranz J, et al. ColoLipidGene: signature of lipid metabolismrelated genes to predict prognosis in stageⅡ colon cancer patients[J]. Oncotarget, 2015, 6(9): 73487363. DOI: 10.18632/oncotarget.3130.
[6] Lv J, Fu Z, Shi M, et al. Systematic analysis of gene expression pattern in hasmiR760 overexpressed resistance of the MCF7 human breast cancer cell to doxorubicin[J]. Biomed Pharmacother, 2015, 69(69): 162169. DOI: 10.1016/j.biopha.2014.11.028.
[7] Prochazka L, Koudelka S, Dong LF, et al. Mitochondrial targeting overcomes ABCA1dependent resistance of lung carcinoma to αtocopheryl succinate[J]. Apoptosis, 2013, 18(3): 286299. DOI: 10.1007/s1049501207951.
[8] Tang C, Houston BA, Storey C, et al. Both STAT3 activation and cholesterol efflux contribute to the antiinflammatory effect of apoAI/ABCA1 interaction in macrophages[J]. J Lipid Res, 2016, 57(5): 848857. DOI: 10.1194/jlr.M065797.
[9] Ramírez CM, Lin CS, Abdelmohsen K, et al. RNA binding protein HuR regulates the expression of ABCA1[J]. J Lipid Res, 2014, 55(6): 10661076. DOI: 10.1194/jlr.M044925.
[10] Jan A, Karasinska JM, Kang MH, et al. Direct intracerebral delivery of a miR33 antisense oligonucleotide into mouse brain increases brain ABCA1 expression[J]. Neurosci Lett, 2015, 598(598): 6672. DOI: 10.1016/j.neulet.2015.05.007.
[11] Kaneko T, Kanno C, IchikawaTomikawa N, et al. Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via upregulation of ABCA1 expression[J]. Oncotarget, 2015, 6(32): 3334533357. DOI: 10.18632/oncotarget.5428.
[12] Dufour J, Pommier A, Alves G, et al. Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell[J]. PLoS One, 2013, 8(3): e58876. DOI: 10.1371/journal.pone.0058876.
[13] Yang CM, Lu YL, Chen HY, et al. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgenindependent prostate cancer cells via the PPARγLXRαABCA1 pathway[J]. J Nutr Biochem, 2012, 23(9): 11551162. DOI: 10.1016/j.jnutbio.2011.06.009.
[14] Huang CX, Zhang YL, Wang JF, et al. MCP1 impacts RCT by repressing ABCA1, ABCG1, and SRBI through PI3K/Akt posttranslational regulation in HepG2 cells[J]. J Lipid Res, 2013, 54(5): 12311240. DOI: 10.1194/jlr.M032482.
[15] Mo W, Zhang J, Li X, et al. Identification of novel ARtargeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer[J]. PLoS One, 2013, 8(2): e56592. DOI: 10.1371/journal.pone.0056592.
[16] Leon CG, Locke JA, Adomat HH, et al. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castrationresistant prostate cancer in a mouse xenograft model[J]. Prostate, 2010, 70(4): 390400. DOI: 10.1002/pros.21072.
[17] Mulay V, Wood P, Manetsch M, et al. Inhibition of mitogenactivated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells[J]. PLoS One, 2013, 8(4): e62667. DOI: 10.1371/journal.pone.0062667.
[18] Jones RJ, Gu D, Bjorklund CC, et al. The novel anticancer agent JNJ26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1[J]. J Pharmacol Exp Ther, 2013, 346(3): 381392. DOI: 10.1124/jpet.113.204958.
[19] Pommier AJ. Alves G, Viennois E, et al. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apotosis of prostate cancer cells[J]. Oncogene, 2012, 29: 27122723. DOI: 10.1038/onc, 2010 (29): 27122723.
[20] Sun DX, Liao GJ, Liu KG, et al. Endosialinexpressing bone sarcoma stemlike cells are highly tumorinitiating and invasive[J]. Mol Med Rep, 2015, 12(4): 56655670. DOI: 10.3892/mmr.2015.4218.
[21] Bloise E, OrtigaCarvalho TM, Reis FM, et al. ATPbinding cassette transporters in reproduction: a new frontier[J]. Hum Reprod Update, 2016, 22(2): 164181. DOI: 10.1093/humupd/dmv049. |